1. Home
  2. BTU vs IDYA Comparison

BTU vs IDYA Comparison

Compare BTU & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peabody Energy Corporation

BTU

Peabody Energy Corporation

HOLD

Current Price

$28.35

Market Cap

3.5B

Sector

Energy

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$33.31

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTU
IDYA
Founded
2016
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BTU
IDYA
Price
$28.35
$33.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
14
Target Price
$26.71
$49.42
AVG Volume (30 Days)
2.6M
926.1K
Earning Date
10-30-2025
11-04-2025
Dividend Yield
1.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,962,300,000.00
$214,834,000.00
Revenue This Year
N/A
$2,434.86
Revenue Next Year
$19.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5377.66
52 Week Low
$9.61
$13.45
52 Week High
$35.99
$37.08

Technical Indicators

Market Signals
Indicator
BTU
IDYA
Relative Strength Index (RSI) 52.07 49.04
Support Level $27.51 $33.12
Resistance Level $30.29 $37.08
Average True Range (ATR) 1.40 1.49
MACD 0.15 -0.37
Stochastic Oscillator 58.33 3.02

Price Performance

Historical Comparison
BTU
IDYA

About BTU Peabody Energy Corporation

Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. The Seaborne Thermal segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan and other regions.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: